Top compounds associated with response to CTD-3105H18.16


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K02251932 CTRPv2 pan-cancer AAC 0.032 0.4
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.029 0.4
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.03 0.4
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC 0.031 0.4
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.027 0.4
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.029 0.4
mRNA BRD-K13999467 CTRPv2 pan-cancer AAC 0.029 0.4
mRNA GDC-0941 CTRPv2 pan-cancer AAC -0.029 0.4
mRNA MLN2238 CTRPv2 pan-cancer AAC -0.028 0.4
mRNA BRD8958 CTRPv2 pan-cancer AAC 0.032 0.4
Download CSV